Disclosure 0001701247-26-000012-2

SEC FORM 4

$227,649.63

Enliven Therapeutics, Inc. (ELVN)

Sale of 3,900 shares at $58.3717 per share.

Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001701247-26-000012 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Enliven Therapeutics, Inc. (ELVN)." Disclosed 2026-08-19. https://desqlong.com/cards/0001701247-26-000012-2 (retrieved 2026-09-26).